Vaccine hopes boosted by data from Novavax and J&J, but fears over new variants remain - MarketWatch
- Vaccine hopes boosted by data from Novavax and J&J, but fears over new variants remain MarketWatch
- J&J says its one-shot Covid-19 vaccine is 72% effective in the U.S. CNBC Television
- Novavax’s Vaccine Works Well — Except on Variant First Found in South Africa The New York Times
- COVID-19: Johnson & Johnson's single-shot vaccine 85% effective against most severe symptoms Sky News
- Look Out, Pfizer and Moderna: Here Comes Novavax Motley Fool
- View Full Coverage on Google News
from Top stories - Google News https://ift.tt/2MCrqy5
Comments
Post a Comment